MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
27.94
-2.61 (-8.54%)
At close: Mar 9, 2026, 4:00 PM EDT
27.60
-0.34 (-1.22%)
After-hours: Mar 9, 2026, 7:15 PM EDT
MBX Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Market Capitalization | 1,317 | 616 | - | - |
| Enterprise Value | 926 | 339 | - | - |
| Last Close Price | 30.55 | 18.43 | - | - |
| PB Ratio | 3.52 | 2.39 | - | - |
| P/TBV Ratio | 3.40 | 2.39 | - | - |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.01 |
| Net Debt / Equity Ratio | -1.01 | -1.02 | -1.01 | -1.02 |
| Net Debt / EBITDA Ratio | 4.32 | 3.86 | 2.29 | 1.67 |
| Net Debt / FCF Ratio | 4.96 | 4.72 | 2.50 | 1.78 |
| Quick Ratio | 32.60 | 23.78 | 20.60 | 12.42 |
| Current Ratio | 32.96 | 24.19 | 21.26 | 12.89 |
| Return on Equity (ROE) | -24.43% | -36.71% | -53.75% | - |
| Return on Assets (ROA) | -16.64% | -24.17% | -34.14% | - |
| Return on Capital Employed (ROCE) | -23.40% | -26.50% | -44.00% | -60.40% |
| Earnings Yield | -6.11% | -10.05% | - | - |
| FCF Yield | -5.99% | -9.02% | - | - |
| Buyback Yield / Dilution | -1225.35% | -944.70% | -52.73% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.